After more than 11 years of injuries and a death, the manufacturer of blood glucose monitors has issued a correction to the ...

McKesson’s fourth-quarter results met Wall Street’s revenue expectations and modestly exceeded consensus for non-GAAP earnings per share, with the market responding positively. Management attributed ...

Europe Retail Pharmacy Market, highlighting steady and resilient growth across the region. The market is projected to expand from USD 380,566.14 million in 2024 to USD 489,130.36 million by 2032, ...

IRVING, Texas – McKesson has reported $3 billion in revenues for the third quarter of fiscal year 2026 for its Medical-Surgical Solutions segment, a 1% increase, driven by higher volumes of specialty ...

Credence Research Inc. announces the publication of its latest report on the Global Retail Pharmacy Market, which is projected to grow from USD 1,445.9 billion in 2024 to USD 1,965.9 billion by 2032, ...

McKesson (MCK), a prominent pharmaceutical wholesaler, experienced a stock increase of 17% during a high-volume trading session. The driver for this surge was a strong Q3 earnings report that ...

(RTTNews) - Shares of McKesson Corporation (MCK) are climbing about 16 percent on Thursday morning trading despite no corporate-related announcements to impact the movement. The company's shares are ...

Brian Tyler, CEO & Director, emphasized the company's continued momentum in oncology, biopharma services, and North American distribution, stating, "Revenue and adjusted EPS grew double digits, driven ...

Feb 4 (Reuters) - McKesson Corporation (MCK.N), opens new tab raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.